Proehl Investment Ventures Llc Insider Trades

Insider Trading History

Track insider trading activity for Proehl Investment Ventures Llc. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $38.6k 2,819,904 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.25M 1,247,904 shares
$1.00
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $1.97M 1,572,000 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$222M 181,585 shares
$1,224.00
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $1.74M 1,390,415 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$137M 111,951 shares
$1,224.00
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $1.6M 1,278,464 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$442M 361,147 shares
$1,224.00
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $35k 27,987 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$34.3M 27,987 shares
$1,224.00
$1.25
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $0 0 shares
Last Trade
Aug 17, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$702M 573,750 shares
$1,224.00
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $21.5k 1,572,000 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$181k 181,585 shares
$1.00
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $19k 1,390,415 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$112k 111,951 shares
$1.00
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $17.5k 1,278,464 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$361k 361,147 shares
$1.00
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $383 27,987 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$28k 27,987 shares
$1.00
$0.01
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $0 0 shares
Last Trade
Aug 17, 2021 Sale (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$573k 573,750 shares
$1.00
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $3.52M 2,819,904 shares
Last Trade
Aug 17, 2021 Purchase (Conversion)Shares acquired or disposed through conversion of a derivative or other security.
$1.53B 1,247,904 shares
$1,224.00
$1.25
Dermata Therapeutics- Warrants (13/08/2026)
Dermata Therapeutics- Warrants (13/08/2026) DRMAW
Director
Holding Value $0 0 shares
Last Trade
Aug 12, 2021 Sale
No data
No data
$0.01
Dermata Therapeutics
Dermata Therapeutics DRMA
Director
Holding Value $0 0 shares
Last Trade
Aug 12, 2021 Sale
No data
No data
$1.25

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up